• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺原位导管癌:疾病模式与治疗的意义

In situ ductal carcinoma of the breast: implications of disease pattern and treatment.

作者信息

Fentiman I S, Fagg N, Millis R R, Hayward J L

出版信息

Eur J Surg Oncol. 1986 Sep;12(3):261-6.

PMID:3019778
Abstract

Ninety-seven patients with in situ ductal carcinoma (DCIS) of the breast have been reviewed. The commonest presenting feature was a breast lump, and residual carcinoma was found in the mastectomy specimen in 63% of patients. Furthermore, 13 cases had evidence of infiltrating carcinoma when the mastectomy specimen was examined. Thus excision alone would have left residual in situ or infiltrating carcinoma in two-thirds of the cases. A wide excision, by removing local residual disease, would still have left multifocal disease in one-third of cases. Studies need to be conducted to determine whether conservative treatment of DCIS can yield results which are as good as those following total mastectomy.

摘要

对97例乳腺导管原位癌(DCIS)患者进行了回顾性研究。最常见的临床表现是乳腺肿块,63%的患者在乳房切除标本中发现残留癌。此外,在检查乳房切除标本时,有13例存在浸润性癌的证据。因此,仅行切除手术会使三分之二的病例残留原位癌或浸润性癌。广泛切除虽然能去除局部残留病灶,但仍会使三分之一的病例存在多灶性病变。需要开展研究来确定对DCIS进行保守治疗是否能取得与全乳房切除相当的效果。

相似文献

1
In situ ductal carcinoma of the breast: implications of disease pattern and treatment.乳腺原位导管癌:疾病模式与治疗的意义
Eur J Surg Oncol. 1986 Sep;12(3):261-6.
2
The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.切除活检显示粉刺型原位导管癌后发生隐匿性浸润性乳腺癌的风险。
Can J Surg. 1989 Jan;32(1):56-60.
3
Therapy of in situ cancer.原位癌的治疗。
Hematol Oncol Clin North Am. 1989 Dec;3(4):691-708.
4
Recent trends in the management of breast cancer. 1. Carcinoma in situ of the breast.乳腺癌管理的最新趋势。1. 乳腺原位癌
Can J Surg. 1992 Aug;35(4):361-5.
5
Influence of local treatment on the recurrence rate of ductal carcinoma in situ.局部治疗对导管原位癌复发率的影响。
J Am Coll Surg. 1995 Jun;180(6):683-8.
6
Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.导管内乳腺癌是否呈节段性扩散?一项使用瘤床活检对节段性乳房切除术后残余肿瘤负荷的分析。
Eur J Surg Oncol. 2001 Feb;27(1):21-5. doi: 10.1053/ejso.2000.1051.
7
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.保留乳头的乳房切除术联合术中放疗(ELIOT):一种用于乳腺癌治疗的新型乳房切除术。
Breast Cancer Res Treat. 2006 Mar;96(1):47-51. doi: 10.1007/s10549-005-9033-7. Epub 2005 Oct 27.
8
Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.微浸润性乳腺癌:单机构经验的临床病理分析
Cancer. 2000 Mar 15;88(6):1403-9.
9
Optimal management of ductal carcinoma in situ of the breast.乳腺导管原位癌的优化管理
Surg Oncol. 2003 Dec;12(4):221-40. doi: 10.1016/S0960-7404(03)00031-8.
10
Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.导管原位癌保守手术及放疗后的局部复发:家族史的潜在重要性
Cancer J Sci Am. 1995 May-Jun;1(1):55-61.

引用本文的文献

1
Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.乳腺导管原位癌中G1/S调节蛋白的组织芯片分析表明,细胞周期蛋白D1水平低与局部复发相关。
Br J Cancer. 2003 Nov 17;89(10):1920-6. doi: 10.1038/sj.bjc.6601398.
2
The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ.完整切除在预防导管原位癌局部复发中的重要性。
Br J Cancer. 1998;77(1):110-4. doi: 10.1038/bjc.1998.17.
3
Clinical decision-making in early breast cancer.
早期乳腺癌的临床决策
Ann Surg. 1993 Mar;217(3):207-25.
4
Management of in situ and minimally invasive breast carcinoma.原位及微创性乳腺癌的管理
World J Surg. 1994 Jan-Feb;18(1):45-57. doi: 10.1007/BF00348191.
5
Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.浸润性乳腺癌的预后变量:粉刺型与非粉刺型原位成分的作用。
Ann Surg Oncol. 1995 Sep;2(5):440-4. doi: 10.1007/BF02306378.
6
Current management of ductal carcinoma in situ.导管原位癌的当前管理
West J Med. 1995 Oct;163(4):360-6.
7
In situ breast carcinomas: a population-based study on frequency, growth pattern, and clinical aspects.
World J Surg. 1988 Dec;12(6):845-51. doi: 10.1007/BF01655494.
8
Wide excision of primary breast cancer: the incidence of residual carcinoma at the site of excision.原发性乳腺癌的广泛切除:切除部位残留癌的发生率。
Ann R Coll Surg Engl. 1988 Jul;70(4):246-8.
9
Impact of an extensive in situ component on the presence of residual disease in screen detected breast cancer.广泛原位成分对筛查发现的乳腺癌中残余疾病存在情况的影响。
J R Soc Med. 1991 Nov;84(11):652-6. doi: 10.1177/014107689108401108.
10
Non-invasive breast carcinoma.非侵袭性乳腺癌
Breast Cancer Res Treat. 1992;21(3):155-64. doi: 10.1007/BF01974998.